| Typicality: | 0.313 |
| Saliency: | 0.149 |
| in infants | 14 | other |
| currently | 7 | temporal |
| therapy → be evaluated in → a phase 1/2 multicenter trial | 7 |
| negative | neutral | positive |
| 0.017 | 0.952 | 0.031 |
| Raw frequency | 7 |
| Normalized frequency | 0.149 |
| Modifier score | 0.500 |
| Perplexity | 22.244 |